B

BMY

NYSE

BRISTOL MYERS SQUIBB CO

Latest disclosureOctober 5, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 4 sales

Price by TradingView

Insider transactions 43

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. Sales: $403.5K by 1 insider.

Sale disclosed

Cristian Massacesi

EVP,Chief Med Offr,Head of Dev

Common Stock, $0.10 par value

Reported value: $403.5K
Reported price: $64.57 / share

Sale disclosed

Phil M. Holzer

SVP and Controller

Common Stock, $0.10 par value

Reported value: $33.75K
Reported price: $67.50 / share

Sale disclosed

David V. Elkins

EVP, Chief Financial Officer

Common Stock, $0.10 par value

Reported value: $1.57M
Reported price: $61.60 / share

Sale disclosed

David V. Elkins

EVP, Chief Financial Officer

Common Stock, $0.10 par value

Reported value: $278.05K
Reported price: $62.05 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
EVP,Chief Med Offr,Head of Dev	Common Stock, $0.10 par valueSale	6,249$64.57 / share	$403.5K	Sep 9Filed Sep 10 · 1d later	SEC filing
SVP and Controller	Common Stock, $0.10 par valueSale	500$67.50 / share	$33.75K	Aug 25Filed Aug 26 · 1d later	SEC filing
EVP, Chief Financial Officer	Common Stock, $0.10 par valueSale10b5-12 trades	30,000avg $61.67 / share	$1.85M	Apr 1Filed Apr 2 · 1d later	2 filings 25,519 @ $61.60 · $1.57MSEC filing 4,481 @ $62.05 · $278.05KSEC filing

Congress transactions 10

All Congress filings

Full sale disclosedAmended report

Bristol-Myers Squibb Company · Stock

The filing reports a full sale for the member.

Thomas H Tuberville official portrait

Thomas H TubervilleReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: April 15, 2025

Purchase disclosed

Bristol-Myers Squibb Company Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Sale disclosed

Bristol-Myers Squibb Company Common Stock (BMY) · Stock

The filing reports a sale for a spouse.

Mike Kelly official portrait

Mike KellyReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: May 7, 2026

Sale disclosed

Bristol-Myers Squibb Company Common Stock (BMY) · Stock

The filing reports a sale for a joint account.

Julie Johnson official portrait

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 18, 2025

Sale disclosed

Bristol-Myers Squibb Company Common Stock (BMY) · Stock

The filing reports a sale for the member.

Julia Letlow official portrait

Julia LetlowReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: April 28, 2025

Purchase disclosed

Bristol-Myers Squibb Company Common Stock (BMY) · Stock

The filing reports a purchase for the member.

Julia Letlow official portrait

Julia LetlowReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 23, 2024

Purchase disclosed

Bristol-Myers Squibb Company Common Stock (BMY) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portrait

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 19, 2025

Purchase disclosed

Bristol-Myers Squibb Company Common Stock (BMY) · Stock

The filing reports a purchase for the member.

Gilbert Cisneros official portrait

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 12, 2025

Partial sale disclosed

Bristol-Myers Squibb Company Common Stock (BMY) · Stock

The filing reports a partial sale for a joint account.

Julie Johnson official portrait

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 13, 2025

Partial sale disclosed

Bristol-Myers Squibb Company Common Stock (BMY) · Stock

The filing reports a partial sale for the member.

Gilbert Cisneros official portrait

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 9, 2025

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000014272
Latest public acceptance: Oct 5, 2026, 08:18 PM UTC
Score calculated: Oct 8, 2026, 12:03 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.